4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000120
Chief Medical Officer acquired 102,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ferguson James J. III Chief Medical Officer | 2026-08-10 | Grant or award | +102,400 | 102,400 | D | ||
| Derivatives | |||||||
| Ferguson James J. III Chief Medical Officer | 2026-08-10 | Grant or award · Stock Option | +135,000 | 135,000 | D | ||
Loading xslF345X06/wk-form4_1786577597.xml…